Baxter acquires True Process to fortify its personalized care offerings

Baxter acquires True Process

Baxter approaches True Process customers, states, “We value the relationships with existing True Process customers, and look forward to working with you.”

Baxter International Inc., a Fortune 500 American health care company has recently announced that it has acquired healthcare software developer True Process. A clinical systems connectivity and consulting firm, True Process provides development, management, and implementation of medical devices and software. Moreover, its Vines software platform is designed for bedside data collection and normalization.

Founder Todd Dunsirn, who reportedly stepped down from his position after the acquisition closed, said that the True Process’ software aims to connect the various devices that monitor and collect patient-related data in a hospital. According to reports, at one time, True Process had roughly 50 employees – half of whom worked remotely for client ICU Medical – and pulled in $10 million in revenue.

According to Todd, most of the company’s remaining employees were hired at Baxter following the buyout. Baxter remarked, “We acquired True Process because we share a passion for innovative technologies that advance smarter and more personalized care.”

Earlier in January 2019, Baxter launched an FDA-cleared trial of its on-demand peritoneal dialysis (PD) solution generation system. The innovative system allows improving the patient experience by making PD solutions in small batches in the patient’s home.

Laura Angelini, GM, Renal Care business, Baxter, stated,  “We are on a journey to transform how kidney disease is identified, managed and treated, with a focus on improving outcomes for patients.” Further, she added, “Our on-demand technology is the cornerstone of our innovation pipeline, as we believe the technology will open up new possibilities for therapy delivery while improving the experience for patients today.”

The success of Baxter’s Sharesource platform

Lately, Baxter announced that its Sharesource remote patient management platform has performed more than 5 million home peritoneal dialysis (PD) treatments globally. It is the only two-way telehealth platform offered globally. The platform enables healthcare professionals to remotely monitor and manage home therapy sessions from their offices, which includes the ability to change prescription settings without the patient needing to make an extra visit to the clinic.

Baxter’s initiative to help Indian villages

According to Amish Vyas, MD, Baxter Pharmaceuticals India Private Limited (BPIPL), amongst India’s biggest concerns are water shortages and inadequate access to clean drinking water, which are also major causes for health-related issues. “To deliver on our commitment to support healthy communities, the initial focus of our sustainability efforts will be to make drinking water easily available to villages near Baxter’s manufacturing site in Ahmedabad.”

Baxter is investing approximately $420,000 in the program to enable testing of current water sources to check for purity levels, install a community-level water purification system, organize awareness activities to educate on effects of consuming contaminated water, and help clean local bodies and help prevent waterlogging during monsoons, which can cause flooding. The program is in partnership with advisory firm KPMG as Baxter’s strategic partner, and with the Centre for Environment Education (CEE) as an implementation partner.